Literature DB >> 22772331

Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.

Si Ai1, Jian Zheng, Qing Lin, Rongyan Chen.   

Abstract

BACKGROUND: Minimal-change nephrotic syndrome is an idiopathic disease in which protein leaks through podocytes into the urine. We used proteomic tools to examine differences of plasma protein expression in healthy rats and rats with doxorubicin-induced nephropathy treated with or without prednisone.
METHODS: Healthy three-month-old Sprague-Dawley male rats were randomly chosen for one injection of doxorubicin (5.5 mg/kg) through the caudal vein to induce nephropathy (n = 50) or the same volume of saline (control, n = 20). After 1 week, 25 rats in the nephropathy group received topical prednisone (5.5 mg/kg/day) for 21 days and another 25 rats (untreated nephropathy) and the control rats received topical water. At 4 weeks, protein chips generated from rat plasma samples were analyzed by surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF-MS) to obtain mass-to-charge ratios (m/z) of proteins of 2-50 kDa.
RESULTS: Relative to control rats, untreated nephropathic rats had four significantly higher and seven significantly lower m/z peaks. Prednisone treatment significantly normalized the intensities of peaks 9069 and 15005 (which correspond to cortexin-1 and interleukin-17A, respectively, according to Swiss Prot database) by increasing the expression of 9069 but reducing expression of 15005.
CONCLUSION: Significant differences in plasma proteins can be identified by proteomic analysis using SELDI-TOF-MS in a rat model of nephropathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772331     DOI: 10.1007/s10157-012-0662-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  38 in total

1.  Identification and proteomic profiling of exosomes in human urine.

Authors:  Trairak Pisitkun; Rong-Fong Shen; Mark A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 2.  Current two-dimensional electrophoresis technology for proteomics.

Authors:  Angelika Görg; Walter Weiss; Michael J Dunn
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

Review 3.  Immuno-MALDI-TOF MS: new perspectives for clinical applications of mass spectrometry.

Authors:  Katrin Sparbier; Thomas Wenzel; Hassan Dihazi; Sabine Blaschke; Gerhard-Anton Müller; André Deelder; Thomas Flad; Markus Kostrzewa
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

4.  Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.

Authors:  Elsa González; Thomas Neuhaus; Markus J Kemper; Eric Girardin
Journal:  Nephrol Dial Transplant       Date:  2008-08-12       Impact factor: 5.992

5.  Detection of two distinct forms of apoC-I in great apes.

Authors:  Donald L Puppione; Christopher M Ryan; Sara Bassilian; Puneet Souda; Xinshu Xiao; Oliver A Ryder; Julian P Whitelegge
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2010-03       Impact factor: 2.674

6.  Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Authors:  André Oberthuer; Frank Berthold; Patrick Warnat; Barbara Hero; Yvonne Kahlert; Rüdiger Spitz; Karen Ernestus; Rainer König; Stefan Haas; Roland Eils; Manfred Schwab; Benedikt Brors; Frank Westermann; Matthias Fischer
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

7.  Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

Authors:  T Bertani; A Poggi; R Pozzoni; F Delaini; G Sacchi; Y Thoua; G Mecca; G Remuzzi; M B Donati
Journal:  Lab Invest       Date:  1982-01       Impact factor: 5.662

8.  Increased urinary excretion of interleukin-17 in nephrotic patients.

Authors:  Koichi Matsumoto; Katsuo Kanmatsuse
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

9.  In silico-initiated cloning and molecular characterization of cortexin 3, a novel human gene specifically expressed in the kidney and brain, and well conserved in vertebrates.

Authors:  Hai Tao Wang; Ji Wu Chang; Zhi Guo; Bao Guo Li
Journal:  Int J Mol Med       Date:  2007-10       Impact factor: 4.101

10.  Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots.

Authors:  Rembert Pieper; Christine L Gatlin; Andrew M McGrath; Anthony J Makusky; Madhu Mondal; Michael Seonarain; Erin Field; Courtney R Schatz; Marla A Estock; Nasir Ahmed; Norman G Anderson; Sandra Steiner
Journal:  Proteomics       Date:  2004-04       Impact factor: 3.984

View more
  1 in total

1.  Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.

Authors:  Limin Li; Tao Zhang; Wenli Diao; Fangfang Jin; Lei Shi; Jiao Meng; Huan Liu; Jing Zhang; Cai-Hong Zeng; Ming-Chao Zhang; Shaoshan Liang; Yuan Liu; Chen-Yu Zhang; Zhihong Liu; Ke Zen
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.